Becton, Dickinson and Company (BDX) To Go Ex-Dividend on December 7th

Becton, Dickinson and Company (NYSE:BDX) announced a quarterly dividend on Monday, November 20th, RTT News reports. Investors of record on Friday, December 8th will be given a dividend of 0.75 per share by the medical instruments supplier on Friday, December 29th. This represents a $3.00 annualized dividend and a yield of 1.37%. The ex-dividend date of this dividend is Thursday, December 7th. This is a positive change from Becton, Dickinson and’s previous quarterly dividend of $0.73.

Becton, Dickinson and has increased its dividend by an average of 10.1% per year over the last three years and has raised its dividend every year for the last 45 years. Becton, Dickinson and has a dividend payout ratio of 28.2% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Becton, Dickinson and to earn $11.80 per share next year, which means the company should continue to be able to cover its $3.00 annual dividend with an expected future payout ratio of 25.4%.

Shares of Becton, Dickinson and (BDX) opened at $219.07 on Wednesday. The company has a market capitalization of $49,909.01, a PE ratio of 23.07, a P/E/G ratio of 1.71 and a beta of 1.07. Becton, Dickinson and has a 1-year low of $161.29 and a 1-year high of $229.68. The company has a current ratio of 5.58, a quick ratio of 5.03 and a debt-to-equity ratio of 1.44.

Becton, Dickinson and (NYSE:BDX) last posted its earnings results on Thursday, November 2nd. The medical instruments supplier reported $2.40 EPS for the quarter, topping the consensus estimate of $2.37 by $0.03. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.14 billion. Becton, Dickinson and had a return on equity of 20.56% and a net margin of 8.52%. Becton, Dickinson and’s revenue for the quarter was down 2.0% compared to the same quarter last year. During the same period last year, the company earned $2.12 earnings per share. analysts predict that Becton, Dickinson and will post 10.63 EPS for the current year.

Several analysts have commented on BDX shares. Piper Jaffray Companies reissued a “buy” rating and issued a $213.00 price objective on shares of Becton, Dickinson and in a report on Tuesday, September 12th. Royal Bank Of Canada reissued a “hold” rating and issued a $210.00 price objective on shares of Becton, Dickinson and in a report on Wednesday, October 25th. Zacks Investment Research lowered Becton, Dickinson and from a “hold” rating to a “sell” rating in a report on Monday, October 9th. Morgan Stanley raised their price objective on Becton, Dickinson and from $205.00 to $245.00 and gave the company an “equal weight” rating in a report on Friday, November 3rd. Finally, Stifel Nicolaus reissued a “buy” rating and issued a $245.00 price objective on shares of Becton, Dickinson and in a report on Friday, November 3rd. Four analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $217.08.

In related news, insider Stephen Sichak sold 11,787 shares of Becton, Dickinson and stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $200.46, for a total transaction of $2,362,822.02. Following the transaction, the insider now owns 14,038 shares in the company, valued at $2,814,057.48. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Gary M. Cohen sold 15,512 shares of Becton, Dickinson and stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $203.77, for a total value of $3,160,880.24. Following the transaction, the insider now owns 95,781 shares in the company, valued at approximately $19,517,294.37. The disclosure for this sale can be found here. Company insiders own 1.40% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Becton, Dickinson and Company (BDX) To Go Ex-Dividend on December 7th” was reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this piece on another domain, it was copied illegally and republished in violation of United States & international copyright & trademark law. The correct version of this piece can be accessed at https://www.chaffeybreeze.com/2017/12/06/becton-dickinson-and-company-bdx-to-go-ex-dividend-on-december-7th.html.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Dividend History for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply